University of Cambridge
News

Cambridge Enterprise licenses cholangiocyte stem cell technology to DefiniGEN

26 April 2017
News

Portfolio company Mission Therapeutics awarded research grant from the Michael J Fox Foundation

11 April 2017
News

Storm Therapeutics announces appointment of CEO and Chairman

24 February 2017
News

An update from Apollo Therapeutics

22 February 2017
News

Cambridge Enterprise joins in £14m funding round for spin-out ApcinteX Limited

02 February 2017
News

University spin-out Cambridge Graphene acquired by Versarien

20 January 2017
News

Cambridge and Kew join forces to find new antimicrobial substances in plants

16 January 2017
News

Cambridge Enterprise joins £2.4 million funding for Cytora

13 January 2017
News

Ventilation technology spin-out Breathing Buildings acquired by Volution Group Plc

20 December 2016
News

Cambridge Enterprise licenses PARP inhibitor drug IP to Cycle Pharmaceuticals

19 December 2016
News

Cambridge Enterprise licenses IP to produce platelets from stem cells

15 December 2016
News

Frontier IP acquires 20% stake in University of Cambridge spin-out Tarsis Technology

07 December 2016